153 related articles for article (PubMed ID: 22547081)
1. The 18 kDa translocator protein influences angiogenesis, as well as aggressiveness, adhesion, migration, and proliferation of glioblastoma cells.
Bode J; Veenman L; Caballero B; Lakomek M; Kugler W; Gavish M
Pharmacogenet Genomics; 2012 Jul; 22(7):538-50. PubMed ID: 22547081
[TBL] [Abstract][Full Text] [Related]
2. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.
Zeno S; Zaaroor M; Leschiner S; Veenman L; Gavish M
Biochemistry; 2009 Jun; 48(21):4652-61. PubMed ID: 19358520
[TBL] [Abstract][Full Text] [Related]
3. Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling.
Yasin N; Veenman L; Singh S; Azrad M; Bode J; Vainshtein A; Caballero B; Marek I; Gavish M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387723
[TBL] [Abstract][Full Text] [Related]
4. Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate.
Veenman L; Bode J; Gaitner M; Caballero B; Peʼer Y; Zeno S; Kietz S; Kugler W; Lakomek M; Gavish M
Pharmacogenet Genomics; 2012 Aug; 22(8):606-19. PubMed ID: 22732722
[TBL] [Abstract][Full Text] [Related]
5. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
[TBL] [Abstract][Full Text] [Related]
6. Concentration-dependent bimodal effect of specific 18 kDa translocator protein (TSPO) ligands on cell death processes induced by ammonium chloride: potential implications for neuropathological effects due to hyperammonemia.
Caballero B; Veenman L; Bode J; Leschiner S; Gavish M
CNS Neurol Disord Drug Targets; 2014; 13(4):574-92. PubMed ID: 24168369
[TBL] [Abstract][Full Text] [Related]
7. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine.
Kugler W; Veenman L; Shandalov Y; Leschiner S; Spanier I; Lakomek M; Gavish M
Cell Oncol; 2008; 30(5):435-50. PubMed ID: 18791274
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effect of hemin in colonic epithelial cell line: involvement of 18 kDa translocator protein (TSPO).
Gemelli C; Dongmo BM; Ferrarini F; Grande A; Corsi L
Life Sci; 2014 Jun; 107(1-2):14-20. PubMed ID: 24792517
[TBL] [Abstract][Full Text] [Related]
9. PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells.
Chelli B; Salvetti A; Da Pozzo E; Rechichi M; Spinetti F; Rossi L; Costa B; Lena A; Rainaldi G; Scatena F; Vanacore R; Gremigni V; Martini C
J Cell Biochem; 2008 Oct; 105(3):712-23. PubMed ID: 18668527
[TBL] [Abstract][Full Text] [Related]
10. The nitric oxide donor sodium nitroprusside requires the 18 kDa Translocator Protein to induce cell death.
Shargorodsky L; Veenman L; Caballero B; Pe'er Y; Leschiner S; Bode J; Gavish M
Apoptosis; 2012 Jul; 17(7):647-65. PubMed ID: 22544277
[TBL] [Abstract][Full Text] [Related]
11. The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS).
Zeno S; Veenman L; Katz Y; Bode J; Gavish M; Zaaroor M
Curr Mol Med; 2012 May; 12(4):494-501. PubMed ID: 22376065
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
13. TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.
Fu Y; Wang D; Wang H; Cai M; Li C; Zhang X; Chen H; Hu Y; Zhang X; Ying M; He W; Zhang J
Neuro Oncol; 2020 Feb; 22(2):240-252. PubMed ID: 31563962
[TBL] [Abstract][Full Text] [Related]
14. TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging.
Denora N; Lee C; Iacobazzi RM; Choi JY; Song IH; Yoo JS; Piao Y; Lopalco A; Leonetti F; Lee BC; Kim SE
Eur J Pharm Sci; 2019 Nov; 139():105047. PubMed ID: 31422171
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma.
Werry EL; King VA; Barron ML; Banister SD; Sokias R; Kassiou M
Eur J Pharm Sci; 2017 Jan; 96():186-192. PubMed ID: 27658888
[TBL] [Abstract][Full Text] [Related]
16. Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo.
Sakai M; Ferraz-de-Paula V; Pinheiro ML; Ribeiro A; Quinteiro-Filho WM; Rone MB; Martinez-Arguelles DB; Dagli ML; Papadopoulos V; Palermo-Neto J
Eur J Pharmacol; 2010 Jan; 626(2-3):131-8. PubMed ID: 19782064
[TBL] [Abstract][Full Text] [Related]
17. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
[TBL] [Abstract][Full Text] [Related]
18. A bispecific antibody (ScBsAbAgn-2/TSPO) target for Ang-2 and TSPO resulted in therapeutic effects against glioblastomas.
Li J; Zhang Z; Lv L; Qiao H; Chen X; Zou C
Biochem Biophys Res Commun; 2016 Apr; 472(2):384-91. PubMed ID: 26898800
[TBL] [Abstract][Full Text] [Related]
19. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers.
Hatty CR; Le Brun AP; Lake V; Clifton LA; Liu GJ; James M; Banati RB
Biochim Biophys Acta; 2014 Mar; 1838(3):1019-30. PubMed ID: 24374318
[TBL] [Abstract][Full Text] [Related]
20. The 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migration.
Wu X; Gallo KA
PLoS One; 2013; 8(8):e71258. PubMed ID: 23967175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
